![]() |
Volumn 17, Issue 9, 2010, Pages 1152-1161
|
Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
SCATTER FACTOR;
ACUTE KIDNEY FAILURE;
ADULT;
AGED;
AMPUTATION;
ANGIOGRAPHY;
ANKLE BRACHIAL INDEX;
ARTICLE;
BACTERIAL PNEUMONIA;
BLADDER PERFORATION;
CEREBELLUM INFARCTION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HEMATOMA;
HUMAN;
LIMB ISCHEMIA;
MALE;
MULTICENTER STUDY;
PAIN;
PERIPHERAL ISCHEMIA;
PERITONITIS;
PLASMID;
PRIORITY JOURNAL;
PROSTATE CANCER;
QUALITY OF LIFE;
RANDOMIZATION;
RANDOMIZED CONTROLLED TRIAL;
REST;
TREATMENT OUTCOME;
ULCER;
ULCER HEALING;
ADULT;
DOUBLE-BLIND METHOD;
FEMALE;
GENE THERAPY;
HEPATOCYTE GROWTH FACTOR;
HUMANS;
ISCHEMIA;
MALE;
NEOVASCULARIZATION, PATHOLOGIC;
PLASMIDS;
TREATMENT OUTCOME;
|
EID: 77956611658
PISSN: 09697128
EISSN: 14765462
Source Type: Journal
DOI: 10.1038/gt.2010.51 Document Type: Article |
Times cited : (183)
|
References (0)
|